Jane Street Group, LLC Guardant Health, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 203,976 shares of GH stock, worth $5.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

203,976

Previous 209,312 2.55%

Holding current value

$5.12 Million

Previous $4.32 Million 36.41%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $85,749 - $169,898	-5,336 Reduced 2.55%	203,976 $5.89 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $469,327 - $737,280	27,398 Added 15.06%	209,312 $4.32 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $2.32 Million - $3.16 Million	107,279 Added 143.74%	181,914 $4.92 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $1.27 Million - $1.96 Million	-49,099 Reduced 39.68%	74,635 $2.21 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $2.57 Million - $4.66 Million	-122,518 Reduced 49.75%	123,734 $4.43 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $1.23 Million - $1.81 Million	53,742 Added 27.92%	246,252 $5.77 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $1.46 Million - $3.43 Million	57,345 Added 42.43%	192,510 $5.24 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $2.61 Million - $3.65 Million	59,832 Added 79.42%	135,165 $7.28 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $2.61 Million - $3.65 Million	59,832 Added 79.42%	135,165 $7.28 Million
Q2 2022 Aug 16, 2022	SELL	$28.82 - $77.35 $826,903 - $2.22 Million	-28,692 Reduced 27.58%	75,333 $3.04 Million
Q1 2022 May 17, 2022	BUY	$48.25 - $100.49 $4.21 Million - $8.77 Million	87,260 Added 520.49%	104,025 $6.89 Million
Q4 2021 Feb 15, 2022	BUY	$88.71 - $120.43 $1.26 Million - $1.72 Million	14,255 Added 567.93%	16,765 $1.68 Million
Q3 2021 Nov 16, 2021	SELL	$98.77 - $132.17 $7.41 Million - $9.91 Million	-74,994 Reduced 96.76%	2,510 $314,000
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $5.6 Million - $8.46 Million	51,043 Added 192.9%	77,504 $9.63 Million
Q1 2021 May 18, 2021	SELL	$127.04 - $179.1 $9.34 Million - $13.2 Million	-73,509 Reduced 73.53%	26,461 $4.04 Million
Q4 2020 Feb 17, 2021	BUY	$99.96 - $135.93 $3.26 Million - $4.44 Million	32,628 Added 48.45%	99,970 $12.9 Million
Q3 2020 Nov 17, 2020	SELL	$80.32 - $111.8 $1.3 Million - $1.8 Million	-16,144 Reduced 19.34%	67,342 $7.53 Million
Q2 2020 Aug 17, 2020	BUY	$60.49 - $97.5 $3.91 Million - $6.3 Million	64,610 Added 342.29%	83,486 $6.77 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $430,460 - $647,513	-7,291 Reduced 27.86%	18,876 $1.31 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $1.18 Million - $1.65 Million	19,919 Added 318.81%	26,167 $2.05 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $385,742 - $679,778	-6,163 Reduced 49.66%	6,248 $399,000
Q2 2019 Aug 15, 2019	BUY	$63.94 - $91.11 $793,559 - $1.13 Million	12,411 New	12,411 $1.07 Million

Others Institutions Holding GH

# of Institutions

331

Shares Held

116M

Call Options Held

680K

Put Options Held

1.66M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.56B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Guardant Health, Inc. Transaction History